Hans-Peter Deigner

Title: Innovations by Hans-Peter Deigner

Introduction

Hans-Peter Deigner is a notable inventor based in Lampertheim, Germany. He has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to asphyxia. With a total of 5 patents to his name, his work has the potential to impact patient care and treatment methodologies.

Latest Patents

One of Hans-Peter Deigner's latest patents is a method for diagnosing and treating asphyxia. This innovative approach involves in vitro diagnosing of asphyxia and related disorders. It also includes a method for estimating the duration of hypoxia in patients subjected to asphyxia. Furthermore, it provides a way to monitor normoxic, hypoxic, and hyperoxic conditions, as well as normobaric and hyperbaric oxygen therapy. The method quantitatively detects a variety of asphyxia-specific endogenous compounds in biological samples. These compounds include biogenic amines, carnitine-derived compounds, amino acids, bile acids, carboxylic acids, eicosanoids, lipids, cholesterol precursors, cholesterol metabolites, prostanoids, and sugars.

Career Highlights

Throughout his career, Hans-Peter Deigner has worked with several companies, including Sirs-lab GmbH and Infandx AG. His experience in these organizations has contributed to his expertise in medical diagnostics and treatment innovations.

Collaborations

Hans-Peter has collaborated with notable coworkers such as Stefan Russwurm and Matthias Keller. Their combined efforts have likely enhanced the development of innovative solutions in their field.

Conclusion

Hans-Peter Deigner's contributions to medical diagnostics, particularly in the area of asphyxia, showcase his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing healthcare through scientific research and collaboration.